NCT02646969View on ClinicalTrials.gov

Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life

NACompletedINTERVENTIONAL
Enrollment

691

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Healthy Term Infants
Interventions
DIETARY_SUPPLEMENT

Formula regimen 1

DIETARY_SUPPLEMENT

Formula regimen 2

Trial Locations (9)

13000

Assistance Publique-Hôpitaux de Marseille, Hôpital de la Conception, Marseille

Assistance Publique-Hôpitaux de Marseille, Hôpital NORD, Marseille

33000

CHU Pellegrin, Bordeaux

54511

CHU de Nancy - Hôpital Brabois, Nancy

59037

Centre Hospitalier Régional Universitaire de Lille, Lille

69229

Hospices Civils de LYON - Hopital de La Croix Rousse, Lyon

69500

Hospices Civils de LYON - Hôpital Femme Mère Enfant de Bron, Bron

76031

CHU - Hôpitaux de ROUEN, Rouen

76130

Centre Hospitalier du Belvédère, Mont-Saint-Aignan

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT02646969 - Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life | Biotech Hunter | Biotech Hunter